-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.

Zhitongcaijing·09/18/2026 08:09:03
Listen to the news
Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.